- Home
- HQI vs NKTR Comparison
HQI vs NKTR Comparison
Compare HQI & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- NKTR
- Stock Information
- Founded
- HQI 2002
- NKTR 1990
- Country
- HQI United States
- NKTR United States
- Employees
- HQI N/A
- NKTR N/A
- Industry
- HQI Professional Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- HQI Consumer Discretionary
- NKTR Health Care
- Exchange
- HQI Nasdaq
- NKTR Nasdaq
- Market Cap
- HQI 143.3M
- NKTR 125.5M
- IPO Year
- HQI N/A
- NKTR 1994
- Fundamental
- Price
- HQI $10.06
- NKTR $8.51
- Analyst Decision
- HQI Strong Buy
- NKTR Strong Buy
- Analyst Count
- HQI 2
- NKTR 6
- Target Price
- HQI $16.00
- NKTR $73.75
- AVG Volume (30 Days)
- HQI 9.7K
- NKTR 352.6K
- Earning Date
- HQI 08-07-2025
- NKTR 08-07-2025
- Dividend Yield
- HQI 2.38%
- NKTR N/A
- EPS Growth
- HQI N/A
- NKTR N/A
- EPS
- HQI 0.24
- NKTR N/A
- Revenue
- HQI $33,651,000.00
- NKTR $87,248,000.00
- Revenue This Year
- HQI N/A
- NKTR N/A
- Revenue Next Year
- HQI $4.99
- NKTR N/A
- P/E Ratio
- HQI $38.65
- NKTR N/A
- Revenue Growth
- HQI N/A
- NKTR N/A
- 52 Week Low
- HQI $9.04
- NKTR $6.48
- 52 Week High
- HQI $15.75
- NKTR $22.79
- Technical
- Relative Strength Index (RSI)
- HQI 50.60
- NKTR 42.19
- Support Level
- HQI $9.71
- NKTR $7.99
- Resistance Level
- HQI $10.24
- NKTR $9.71
- Average True Range (ATR)
- HQI 0.27
- NKTR 1.37
- MACD
- HQI 0.05
- NKTR -0.20
- Stochastic Oscillator
- HQI 64.81
- NKTR 11.66
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.